PYCR1 and breast carcinoma: Results obtained with myelogenous leukaemia K562 cells, which grow in suspension to highest densities36, were confirmed with substrate-adhering breast cancer MDA-MB-231 cells that were chosen as a validated system in which PYCR1 is overexpressed and its inhibition causes the reduction of growth and invasion capabilities.45